These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35281472)

  • 21. Integrative analysis from multi-center studies identifies a weighted gene co-expression network analysis-based Tregs signature in ovarian cancer.
    Cao Y; Liu YL; Lu XY; Kai HL; Han Y; Zheng YL
    Environ Toxicol; 2024 Feb; 39(2):736-750. PubMed ID: 37713585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in Ovarian Cancer.
    Pi Y; Sun F; Zhang Z; Liu X; Lou G
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512088
    [No Abstract]   [Full Text] [Related]  

  • 23. Multi-Omics Profiling Identifies Risk Hypoxia-Related Signatures for Ovarian Cancer Prognosis.
    Chen X; Lan H; He D; Xu R; Zhang Y; Cheng Y; Chen H; Xiao S; Cao K
    Front Immunol; 2021; 12():645839. PubMed ID: 34349753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A macrophage related signature for predicting prognosis and drug sensitivity in ovarian cancer based on integrative machine learning.
    Zhao B; Pei L
    BMC Med Genomics; 2023 Oct; 16(1):230. PubMed ID: 37784081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic and immunotherapeutic potential of regulatory T cell-associated signature in ovarian cancer.
    Liu Y; Shan F; Sun Y; Kai H; Cao Y; Huang M; Liu J; Zhang P; Zheng Y
    J Cell Mol Med; 2024 Apr; 28(8):e18248. PubMed ID: 38520220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Immune Microenvironment Related Gene-Based Model to Predict Prognosis and Response to Compounds in Ovarian Cancer.
    Yang J; Hong S; Zhang X; Liu J; Wang Y; Wang Z; Gao L; Hong L
    Front Oncol; 2021; 11():807410. PubMed ID: 34966691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel gene signatures for prognosis prediction in ovarian cancer.
    Bao M; Zhang L; Hu Y
    J Cell Mol Med; 2020 Sep; 24(17):9972-9984. PubMed ID: 32666642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer.
    Ni X; Chen C; Cui G; Ding W; Liu J
    Front Immunol; 2022; 13():932876. PubMed ID: 35837397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.
    Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D
    Front Genet; 2021; 12():692953. PubMed ID: 34490033
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification and validation of a 9-gene signature for the prognosis of ovarian cancer by integrated bioinformatical analysis.
    Chen S; Yang M; Yang H; Tang Q; Gu C; Wei W
    Ann Transl Med; 2022 Oct; 10(19):1059. PubMed ID: 36330389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine learning and bioinformatics models to identify gene expression patterns of ovarian cancer associated with disease progression and mortality.
    Hossain MA; Saiful Islam SM; Quinn JMW; Huq F; Moni MA
    J Biomed Inform; 2019 Dec; 100():103313. PubMed ID: 31655274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and validation of a novel aging-related gene signature and prognostic nomogram for predicting the overall survival in ovarian cancer.
    Liu L; Zhao J; Du X; Zhao Y; Zou C; Zhou H; Li W; Yan X
    Cancer Med; 2021 Dec; 10(24):9097-9114. PubMed ID: 34825509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
    Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and Validation of Angiogenesis-Related Gene Expression for Predicting Prognosis in Patients With Ovarian Cancer.
    Wang Y; Li BX; Li X
    Front Oncol; 2021; 11():783666. PubMed ID: 35047401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a SVM classifier to predict recurrence of ovarian cancer.
    Zhou J; Li L; Wang L; Li X; Xing H; Cheng L
    Mol Med Rep; 2018 Oct; 18(4):3589-3598. PubMed ID: 30106117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer.
    Diao B; Yang P
    Pathol Oncol Res; 2021; 27():1609855. PubMed ID: 34512203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic Construction and Validation of an Immune-Related Gene-Based Model to Predict Prognosis for Ovarian Cancer.
    Fu Y; Sun H
    Biomed Res Int; 2022; 2022():7356992. PubMed ID: 35496047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network.
    Wang X; Han L; Zhou L; Wang L; Zhang LM
    Oncol Rep; 2018 Nov; 40(5):2659-2673. PubMed ID: 30226545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.